“Pay for success” contracts – a model to develop new therapies from old drugs

Pay for Success Contracts — A New Model to Develop New Therapies from Old Drugs The problem — lack of private incentives to repurpose off-patent drugs A golden opportunity is frequently being missed due to lack of financial incentives to study old inexpensive generic drugs for new indications. Imagine that you discovered that a combination of off-patent (“generic”) drugs worked to better treat pancreatic cancer, which otherwise kills 95% of sufferers within five years of diagnosis.

Read the source article at crowdfundedcures.medium.com
2021-09-25 03:54:32